Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Yohimbine: a clinical review.

Tam SW, Worcel M, Wyllie M.

Pharmacol Ther. 2001 Sep;91(3):215-43. Review.

PMID:
11744068
2.

Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.

Crespi F.

J Neurosci Methods. 2009 May 30;180(1):97-105. doi: 10.1016/j.jneumeth.2009.03.007.

PMID:
19427535
4.

Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction.

Lebret T, Hervé JM, Gorny P, Worcel M, Botto H.

Eur Urol. 2002 Jun;41(6):608-13; discussion 613.

PMID:
12074777
5.

Yohimbine in erectile dysfunction: the facts.

Morales A.

Int J Impot Res. 2000 Mar;12 Suppl 1:S70-74. Review.

PMID:
10845767
6.

Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed?

Morales A.

World J Urol. 2001 Aug;19(4):251-5. Review.

PMID:
11550783
7.

Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial.

Guay AT, Spark RF, Jacobson J, Murray FT, Geisser ME.

Int J Impot Res. 2002 Feb;14(1):25-31.

8.

New treatment options for erectile dysfunction in patients with diabetes mellitus.

Basu A, Ryder RE.

Drugs. 2004;64(23):2667-88. Review.

PMID:
15537369
9.
10.

Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.

Yassin A, Saad F, Hoesl CE, Traish AM, Hammadeh M, Shabsigh R.

Andrologia. 2006 Feb;38(1):1-12. Review.

PMID:
16420236
11.

Future options for combination therapy in the management of erectile dysfunction in older men.

Sommer F, Engelmann U.

Drugs Aging. 2004;21(9):555-64. Review.

PMID:
15260511
12.

Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam.

Mattila M, Seppala T, Mattila MJ.

Int Clin Psychopharmacol. 1988 Jul;3(3):215-29.

PMID:
3153710
13.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
14.

Update on oral treatments for male erectile dysfunction.

Kalsi JS, Kell PD.

J Eur Acad Dermatol Venereol. 2004 May;18(3):267-74. Review.

PMID:
15096134
15.

Erectile dysfunction: oral pharmacotherapy options.

Vitezic D, Pelcic JM.

Int J Clin Pharmacol Ther. 2002 Sep;40(9):393-403. Review.

PMID:
12358156
16.

Severe Raynaud's phenomenon with yohimbine therapy for erectile dysfunction.

Johnson S, Iazzetta J, Dewar C.

J Rheumatol. 2003 Nov;30(11):2503-5.

PMID:
14677199
17.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
18.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x.

PMID:
18503626
19.

PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.

Rosen RC, McKenna KE.

Annu Rev Sex Res. 2002;13:36-88. Review.

PMID:
12836729
20.

Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.

Miner M, Rosenberg MT, Perelman MA.

Clin Ther. 2006 Jan;28(1):13-25. Review.

PMID:
16490576
Items per page

Supplemental Content

Support Center